HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The adipokine leptin mediates muscle- and liver-derived IGF-1 in aged mice.

Abstract
Muscle- and liver-derived IGF-1 play important roles in muscle anabolism throughout growth and aging. Yet, prolonged food restriction is thought to increase longevity in part by lowering levels of IGF-1, which in turn reduces the risk for developing various cancers. The dietary factors that modulate IGF-1 levels are, however, poorly understood. We tested the hypothesis that the adipokine leptin, which is elevated with food intake and suppressed during fasting, is a key mediator of IGF-1 levels with aging and food restriction. First, leptin levels in peripheral tissues were measured in young mice fed ad libitum, aged mice fed ad libitum, and aged calorie-restricted (CR) mice. A group of aged CR mice were also treated with recombinant leptin for 10 days. Later, aged mice fed ad libitum were treated with saline (VEH) or with a novel leptin receptor antagonist peptide (Allo-aca) and tissue-specific levels of IGF-1 were determined. On one hand, recombinant leptin induced a three-fold increase in liver-derived IGF-1 and a two-fold increase in muscle-derived IGF-1 in aged, CR mice. Leptin also significantly increased serum growth hormone levels in the aged, CR mice. On the other, the leptin receptor antagonist Allo-aca did not alter body weight or muscle mass in treated mice compared to VEH mice. Allo-aca did, however, produce a significant (20%) decline in liver-derived IGF-1 as well as an even more pronounced (>50%) decrease in muscle-derived IGF-1 compared to VEH-treated mice. The reduced IGF-1 levels in Allo-aca treated mice were not accompanied by any significant change in growth hormone levels compared to VEH mice. These findings suggest that leptin receptor antagonists may represent novel therapeutic agents for attenuating IGF-1 signaling associated with aging, and could potentially mimic some of the positive effects of calorie restriction on longevity.
AuthorsM W Hamrick, A Dukes, P Arounleut, C Davis, S Periyasamy-Thandavan, S Mork, S Herberg, M H Johnson, C M Isales, W D Hill, L Otvos Jr, E J Belin de Chantemèle
JournalExperimental gerontology (Exp Gerontol) Vol. 70 Pg. 92-6 (Oct 2015) ISSN: 1873-6815 [Electronic] England
PMID26220769 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • D-Ser Allo-aca peptide
  • Leptin
  • Peptides
  • Receptors, Leptin
  • Recombinant Proteins
  • Insulin-Like Growth Factor I
  • Growth Hormone
Topics
  • Aging (metabolism)
  • Animals
  • Body Weight (drug effects, physiology)
  • Caloric Restriction
  • Eating
  • Growth Hormone (blood)
  • Insulin-Like Growth Factor I (drug effects, metabolism)
  • Leptin (pharmacology, physiology)
  • Liver (metabolism)
  • Longevity (physiology)
  • Mice
  • Muscle, Skeletal (metabolism)
  • Peptides (pharmacology)
  • Receptors, Leptin (antagonists & inhibitors)
  • Recombinant Proteins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: